Healthcare provider profile · identity verified

Mark Cieniawski, M.D.

Internal Medicine · PORTLAND, ME · NPI 1205870607

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	938	227
Amlodipine Besylate	Amlodipine Besylate	652	176
Metoprolol Succinate	Metoprolol Succinate	580	140
Losartan Potassium	Losartan Potassium	528	134
Lisinopril	Lisinopril	511	143
Pantoprazole Sodium	Pantoprazole Sodium	468	133
Eliquis	Apixaban	414	71
Levothyroxine Sodium	Levothyroxine Sodium	378	87
Rosuvastatin Calcium	Rosuvastatin Calcium	308	80
Furosemide	Furosemide	263	72
Tamsulosin Hcl	Tamsulosin Hcl	252	77
Spironolactone	Spironolactone	242	55
Gabapentin	Gabapentin	223	61
Metoprolol Tartrate	Metoprolol Tartrate	211	59
Jardiance	Empagliflozin	196	34
Warfarin Sodium	Warfarin Sodium	193	19
Metformin Hcl	Metformin Hcl	185	57
Famotidine	Famotidine	183	48
Potassium Chloride	Potassium Chloride	176	39
Albuterol Sulfate Hfa	Albuterol Sulfate	174	63
Omeprazole	Omeprazole	162	51
Sertraline Hcl	Sertraline Hcl	162	42
Allopurinol	Allopurinol	160	42
Pravastatin Sodium	Pravastatin Sodium	150	35
Trazodone Hcl	Trazodone Hcl	145	45
Finasteride	Finasteride	142	36
Clopidogrel	Clopidogrel Bisulfate	136	33
Escitalopram Oxalate	Escitalopram Oxalate	135	39
Prednisone	Prednisone	133	52
Hydrochlorothiazide	Hydrochlorothiazide	129	36
Bumetanide	Bumetanide	127	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	125	36
Simvastatin	Simvastatin	122	38
Ezetimibe	Ezetimibe	114	28
Montelukast Sodium	Montelukast Sodium	109	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	108	23
Carvedilol	Carvedilol	104	29
Bupropion Xl	Bupropion Hcl	102	22
Citalopram Hbr	Citalopram Hydrobromide	93	24
Fluticasone Propionate	Fluticasone Propionate	92	31
Trulicity	Dulaglutide	90	18
Atenolol	Atenolol	84	26
Triamcinolone Acetonide	Triamcinolone Acetonide	81	34
Glipizide	Glipizide	79	23
Ozempic	Semaglutide	76	16
Oxycodone Hcl	Oxycodone Hcl	75	14
Myrbetriq	Mirabegron	72	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	25
Chlorthalidone	Chlorthalidone	70	19
Duloxetine Hcl	Duloxetine Hcl	70	15
Mounjaro	Tirzepatide	66	suppressed
Metformin Hcl Er	Metformin Hcl	59	18
Xarelto	Rivaroxaban	58	suppressed
Meclizine Hcl	Meclizine Hcl	57	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	19
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	53	11
Entresto	Sacubitril/Valsartan	50	suppressed
Donepezil Hcl	Donepezil Hcl	46	11
Nitroglycerin	Nitroglycerin	45	30
Diclofenac Sodium	Diclofenac Sodium	44	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	21
Tramadol Hcl	Tramadol Hcl	42	suppressed
Farxiga	Dapagliflozin Propanediol	41	suppressed
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Folic Acid	Folic Acid	40	suppressed
Lovastatin	Lovastatin	39	11
Doxazosin Mesylate	Doxazosin Mesylate	38	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Pregabalin	Pregabalin	36	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Methenamine Hippurate	Methenamine Hippurate	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Tresiba Flextouch U-200	Insulin Degludec	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Mirtazapine	Mirtazapine	33	11
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Azithromycin	Azithromycin	31	28
Fluoxetine Hcl	Fluoxetine Hcl	31	11
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Amiodarone Hcl	Amiodarone Hcl	30	suppressed
Meloxicam	Meloxicam	29	12
Novolog Flexpen	Insulin Aspart	29	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Baclofen	Baclofen	27	suppressed
Celecoxib	Celecoxib	27	11
Clonazepam	Clonazepam	27	suppressed
Digoxin	Digoxin	27	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Diazepam	Diazepam	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	12
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Latanoprost	Latanoprost	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Ammonium Lactate	Ammonium Lactate	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Nystatin	Nystatin	22	14
Alprazolam	Alprazolam	21	suppressed
Calcitriol	Calcitriol	21	suppressed
Valsartan	Valsartan	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	11
Lorazepam	Lorazepam	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	14
Ramipril	Ramipril	19	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Erythromycin	Erythromycin Base	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Multaq	Dronedarone Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Sotalol	Sotalol Hcl	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Dofetilide	Dofetilide	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Linzess	Linaclotide	14	suppressed
Nystop	Nystatin	14	suppressed
Restasis Multidose	Cyclosporine	14	suppressed
Ursodiol	Ursodiol	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	suppressed
Liothyronine Sodium	Liothyronine Sodium	13	suppressed
Livalo	Pitavastatin Calcium	13	suppressed
Naproxen	Naproxen	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Novolog	Insulin Aspart	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Clotrimazole	Clotrimazole	12	11
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	12	suppressed
Lactulose	Lactulose	12	suppressed
Lasix	Furosemide	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error